Clinical Trial Update: Oral Anticoagulation in Haemodialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating oral anticoagulation in patients on haemodialysis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Kidney Failure, Chronic | Phase 4 | Status: TERMINATED